Corbus Pharmaceuticals
CRBP
CRBP
27 hedge funds and large institutions have $5.01M invested in Corbus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 28 → 27 (-1)
14% less capital invested
Capital invested by funds: $5.8M → $5.01M (-$790K)
Holders
27
Holding in Top 10
–
Calls
$239K
Puts
$4K
Top Buyers
| 1 | +$29.1K | |
| 2 | +$24.5K | |
| 3 | +$24.5K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$10.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.92K |
Top Sellers
| 1 | -$20K | |
| 2 | -$16K | |
| 3 | -$5.26K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.32K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.15K |